|
|
 |
|
What is COPD?
Chronic Obstructive Pulmonary Disease (COPD) refers to a group of diseases that cause airflow blockage and breathing-related problems. It includes emphysema, chronic bronchitis, and in some cases asthma. In the United States, tobacco use is a key factor in the development and progression of COPD, but asthma, exposure to air pollutants in the home and workplace, genetic factors, and respiratory infections also play a role. In the developing world, indoor air quality is thought to play a larger role in the development and progression of COPD than it does in the United States.
Studies
If you are over 40 years old with a history of COPD, EMPHYSEMA, OR BRONCHITIS, and a current or ex-smoker with qualifying pulmonary function tests, you may participate in the following studies.
Tiotropium(Spiriva): A 52 week trial to assess the efficacy & safety of Tiotropium Inhalation in subjects with Chronic Obstructive Pulmonary Disease (COPD)
Symbicort: This is a 12-month study using Symbicort (a long acting bronchodilator/steroid combo) twice a day compared to Formoterol (long acting bronchodilator) twice a day in subjects with COPD.
All qualified participants will receive at no cost:
- Study related physical exam, medical care and medications; and
- Compensation for travel & time
If you are interested in any of the studies or more information, contact Sue or Anna at 314-439-LUNG (5864).
« Back | Top
|
|
|
|
|
|
